MedPath

Disopyramide

Generic Name
Disopyramide
Brand Names
Norpace, Rythmodan
Drug Type
Small Molecule
Chemical Formula
C21H29N3O
CAS Number
3737-09-5
Unique Ingredient Identifier
GFO928U8MQ

Overview

A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.

Background

A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.

Indication

For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, ventricular pre-excitation and cardiac dysrhythmias. It is a Class Ia antiarrhythmic drug.

Associated Conditions

  • Ventricular Arrhythmia

FDA Approved Products

DISOPYRAMIDE PHOSPHATE
Manufacturer:Mayne Pharma Commercial LLC
Route:ORAL
Strength:150 mg in 1 1
Approved: 2023/07/06
NDC:51862-096
Disopyramide Phosphate
Manufacturer:Carilion Materials Management
Route:ORAL
Strength:100 mg in 1 1
Approved: 2015/10/30
NDC:68151-3858
Norpace CR
Manufacturer:Pfizer Laboratories Div Pfizer Inc
Route:ORAL
Strength:100 mg in 1 1
Approved: 2023/08/30
NDC:0025-2732
Norpace
Manufacturer:Pfizer Laboratories Div Pfizer Inc
Route:ORAL
Strength:150 mg in 1 1
Approved: 2023/08/30
NDC:0025-2762
Disopyramide Phosphate
Manufacturer:Teva Pharmaceuticals USA, Inc.
Route:ORAL
Strength:100 mg in 1 1
Approved: 2022/04/28
NDC:0093-3127

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath